store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Rentiapril racemate (SA-446 racemate) 是 Rentiapril 的外消旋体。Rentiapril racemate 具有抗炎活性,可用于研究青光眼。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
2 mg | ¥ 991 | 5日内发货 | ||
5 mg | ¥ 1,660 | 5日内发货 | ||
10 mg | ¥ 2,820 | 5日内发货 | ||
25 mg | ¥ 5,890 | 5日内发货 | ||
50 mg | ¥ 7,960 | 6-8周 |
产品描述 | Rentiapril racemate (SA-446 racemate) is the racemate of Rentiapril.Rentiapril racemate has anti-inflammatory activity and may be used in glaucoma research. |
体内活性 | A three-month toxicity study of Rentiapril (CAS 80830-42-8), an angiotensin-converting enzyme (ACE) inhibitor, is conducted in Sprague-Dawley rats through oral administration. Dose levels of 0, 30, 125, 500, and 1000 mg/kg are tested in both sexes, with each experimental group consisting of 10 rats. Captopril, another ACE inhibitor, is used as a reference compound.At the highest dose of 1000 mg/kg, Rentiapril causes low food consumption and death in some animals, presenting signs of bloody feces and anemia. In males and females receiving 500 and 1000 mg/kg, there are low body weight gain, increases in water intake, urine volume, and serum BUN level, and decreases in various erythrocytic parameters. Kidney weight increases dose-dependently in both sexes. Histopathologically, renal changes in the 500 and 1000 mg/kg groups consist of proximal tubular degeneration, juxtaglomerular cell hyperplasia, and interstitial cell infiltration. Similar but milder changes in proximal tubules are present in the female 125 mg/kg group. Dead animals from the highest dose groups further show gastrointestinal hemorrhagic erosion and/or ulcer, decreased bone marrow erythropoiesis, and hepatocytic vacuolar degeneration. No pathological alterations are observed in rats from other Rentiapril-treated groups or in controls. These results indicate that the no-effect dose of Rentiapril in rats, following three months of oral administration, is 30 mg/kg in females and 125 mg/kg in males[1]. |
别名 | (Rac)-SA-446, SA-446 racemate, (Rac)-Rentiapril |
分子量 | 313.39 |
分子式 | C13H15NO4S2 |
CAS No. | 72679-47-1 |
store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (159.55 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 3.1909 mL | 15.9546 mL | 31.9091 mL | 79.7728 mL |
5 mM | 0.6382 mL | 3.1909 mL | 6.3818 mL | 15.9546 mL | |
10 mM | 0.3191 mL | 1.5955 mL | 3.1909 mL | 7.9773 mL | |
20 mM | 0.1595 mL | 0.7977 mL | 1.5955 mL | 3.9886 mL | |
50 mM | 0.0638 mL | 0.3191 mL | 0.6382 mL | 1.5955 mL | |
100 mM | 0.0319 mL | 0.1595 mL | 0.3191 mL | 0.7977 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Rentiapril racemate 72679-47-1 Metabolism Angiotensin-converting Enzyme (ACE) (Rac)-SA-446 SA-446 racemate (Rac)-Rentiapril Inhibitor inhibitor inhibit